UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 133

Sortiert nach

Modelling mode choice for freight transport using advanced choice experiments

Transportation research. Part A, Policy and practice, 2015-05, Vol.75, p.252-267

2015

Volltextzugriff (PDF)

A latent class model with attribute cut-offs to analyze modal choice for freight transport

Transportation research. Part A, Policy and practice, 2017-08, Vol.102, p.212-227

2017

Volltextzugriff (PDF)

Analyzing discrepancies between willingness to pay and willingness to accept for freight transport attributes

Transportation research. Part E, Logistics and transportation review, 2016-05, Vol.89, p.151-164

2016

Volltextzugriff (PDF)

A Short Term Forecasting Model for the Spanish GDP and its Demand Components

Economía (Lima), 2020-01, Vol.43 (85), p.1-30

2020

Volltextzugriff (PDF)

High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4

Liver international, 2017-12, Vol.37 (12), p.1823-1832

2017

Volltextzugriff (PDF)

Strategies to improve the efficiency of celiac disease diagnosis in the laboratory

Journal of immunological methods, 2017-10, Vol.449, p.62-67

2017

Volltextzugriff (PDF)

Clinical outcomes of direct-acting antiviral therapy in patients with compensated hepatitis C virus-related cirrhosis

Hepatoma research, 2017-09, Vol.3 (9), p.209-214

2017

Volltextzugriff (PDF)

Factors associated with parietal cell autoantibodies in the general population

Immunology letters, 2012-09, Vol.147 (1), p.63-66

2012

Volltextzugriff (PDF)

Improving the diagnosis of primary biliary cholangitis through inmunology protocols

Journal of hepatology, 2023-06, Vol.78, p.S397

2023

Volltextzugriff (PDF)

WED-296 - Improving the diagnosis of primary biliary cholangitis through inmunology protocols

Journal of hepatology, 2023-06, Vol.78, p.S397-S397

2023

Volltextzugriff (PDF)

THU-118 Prophylaxis for tuberculosis and pneumocystis jirovecii does not seem necessary in patients with autoimmune hepatitis treated with corticosteroid therapy: spanish multicentre study

Journal of hepatology, 2024-06, Vol.80, p.S318-S319

2024

Volltextzugriff (PDF)

THU-154-YI Diabetes mellitus (DM) is associated with worse outcomes in patients with primary biliary cholangitis (PBC) regardless of the presence of liver steatosis: results from the ColHai registry

Journal of hepatology, 2024-06, Vol.80, p.S329-S330

2024

Volltextzugriff (PDF)

THU-216 - Real-life effectiveness of voxilaprevir/sofosbuvir/velpatasvir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir

Journal of hepatology, 2023-06, Vol.78, p.S1205-S1206

2023

Volltextzugriff (PDF)

HCV in addiction care: different epidemiology, excellent treatment results

Journal of hepatology, 2020-08, Vol.73, p.S790-S791

2020

Volltextzugriff (PDF)

SAT275 - HCV in addiction care: different epidemiology, excellent treatment results

Journal of hepatology, 2020-08, Vol.73, p.S790-S791

2020

Volltextzugriff (PDF)

1 – 25 von 133

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(110)
Mit Volltextzugriff
(113)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Modelling mode choice for freight transport using advanced choice experiments

A latent class model with attribute cut-offs to analyze modal choice for freight transport

Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration

Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study

Analyzing discrepancies between willingness to pay and willingness to accept for freight transport attributes

A Short Term Forecasting Model for the Spanish GDP and its Demand Components

High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4

Strategies to improve the efficiency of celiac disease diagnosis in the laboratory

Clinical outcomes of direct-acting antiviral therapy in patients with compensated hepatitis C virus-related cirrhosis

Factors associated with parietal cell autoantibodies in the general population

Improving the diagnosis of primary biliary cholangitis through inmunology protocols

WED-296 - Improving the diagnosis of primary biliary cholangitis through inmunology protocols

Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs

WED-172 Transaminase Pattern Over Time Is Not Associated with a More Aggressive Hepatic Evolution: Results from the AEEH Wilson Registry

THU-155 Incidence of fungal and other opportunistic infections in patients with autoimmune hepatitis: a spanish multicentre study

THU-118 Prophylaxis for tuberculosis and pneumocystis jirovecii does not seem necessary in patients with autoimmune hepatitis treated with corticosteroid therapy: spanish multicentre study

THU-154-YI Diabetes mellitus (DM) is associated with worse outcomes in patients with primary biliary cholangitis (PBC) regardless of the presence of liver steatosis: results from the ColHai registry

WED-264 - Impact of the metabolic profile on the response to ursodeoxycholic acid in patients with primary biliary cholangitis: results of the ColHai registry

Impact of the metabolic profile on the response to ursodeoxycholic acid in patients with primary biliary cholangitis: results of the ColHai registry

WED-290 - Predictive models of treatment benefit in patients with autoimmune hepatitis and decompensated cirrhosis at diagnosis

Predictive models of treatment benefit in patients with autoimmune hepatitis and decompensated cirrhosis at diagnosis

Real-life effectiveness of voxilaprevir/sofosbuvir/velpatasvir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir

THU-216 - Real-life effectiveness of voxilaprevir/sofosbuvir/velpatasvir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir

HCV in addiction care: different epidemiology, excellent treatment results

SAT275 - HCV in addiction care: different epidemiology, excellent treatment results

Suchergebnisse filtern